MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.35 0.15 (6.38%)	0.02 (0.81%)	0.04 (1.63%)	-0.25 (-9.09%)	0.15 (6.38%)	-0.01 (-0.75%)	0.9 (67.67%)	1.17 (87.97%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: PreMarket

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -27.7778
Diluted P/E:: -27.7778
RSI(14) 1m:: 69.7
VWAP:: 2.49
RVol:: 9.849

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	2.39 -0.03 (-1.24%)	Oct 16 04:20
1m	Price decrease 1m	2.42 -0.03 (-1.22%)	Oct 16 04:19
1m	Price increase 1m	2.45 +0.04 (+1.66%)	Oct 16 04:18
1m	Price increase 1m	2.41 +0.05 (+2.12%)	Oct 16 04:17
1m	Price decrease 1m	2.36 -0.05 (-2.07%)	Oct 16 04:16